CHEMOHORMONAL THERAPY OF METASTATIC PROSTATE-CANCER - A PILOT-STUDY

被引：0
|
作者：
CITRIN, DL
HOGAN, TF
DAVIS, TE
机构：
[1] UNIV WISCONSIN,CTR CLIN SCI,DEPT HUMAN ONCOL,MADISON,WI 53706
[2] UNIV WISCONSIN,CTR CLIN SCI,DEPT MED,MADISON,WI 53706
[3] WISCONSIN CLIN CANC CTR,MADISON,WI
来源：
CANCER | 1983年 / 52卷 / 03期
关键词：
D O I：
10.1002/1097-0142(19830801)52:3<410::AID-CNCR2820520305>3.0.CO;2-R
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：410 / 414
页数：5
相关论文
共 50 条
  • [41] A multidisciplinary clinic to mitigate the toxicity of therapy for newly diagnosed metastatic prostate cancer undergoing chemohormonal therapy: A feasibility study.
    Hough, Jeffrey
    Rodvelt, Tammy J.
    Thomas, Miles
    Ma, Brian
    Rabow, Michael W.
    Weinberg, Rami
    Macaire, Greta
    Shepard, Nancy
    Chan, June M.
    Van Blarigan, Erin
    Choque-Gonzales, Gonzalo
    Lee, Mina
    Friedlander, Terence W.
    Kim, Won
    Ryan, Charles J.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (05)
  • [42] PHOTODYNAMIC THERAPY OF PROSTATE-CANCER - AN INVITRO STUDY
    CAMPS, JL
    POWERS, SK
    BECKMAN, WC
    BROWN, JT
    WEISSMAN, RM
    JOURNAL OF UROLOGY, 1985, 134 (06): : 1222 - 1226
  • [43] Role of multidisciplinary team meetings in implementation of chemohormonal therapy in metastatic prostate cancer in daily practice
    Creemers, S. G.
    Van Santvoort, B.
    van den Berkmortel, F. W. P. J.
    Kiemeney, L. A.
    van Oort, I. M.
    Aben, K. K. H.
    Hamberg, P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 133 - 141
  • [44] Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882)An eastern cooperative oncology group study
    Andrea N. Leaf
    Kathleen Propert
    Chris Corcoran
    Paul J. Catalano
    Donald L. Trump
    Jules E. Harris
    Thomas E. Davis
    Medical Oncology, 2003, 20 : 137 - 145
  • [45] Chemohormonal Therapy in Hormone-Sensitive Prostate Cancer
    Ciccarese, Chiara
    Santoni, Matteo
    Massari, Francesco
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (03): : 286 - 286
  • [46] Phase III study of combined chemohormonal therapy in metastatic prostate cancer (ECOG 3882) - An eastern cooperative oncology group study
    Leaf, AN
    Propert, K
    Corcoran, C
    Catalano, PJ
    Trump, DL
    Harris, JE
    Davis, TE
    MEDICAL ONCOLOGY, 2003, 20 (02) : 137 - 145
  • [47] Role of multidisciplinary team meetings in implementation of chemohormonal therapy in metastatic prostate cancer in daily practice
    S. G. Creemers
    B. Van Santvoort
    F. W. P. J. van den Berkmortel
    L. A. Kiemeney
    I. M. van Oort
    K. K. H. Aben
    P. Hamberg
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 133 - 141
  • [48] PROGNOSTIC INDICATORS IN METASTATIC PROSTATE-CANCER
    POWERS, WE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (21): : 2808 - 2808
  • [49] HORMONE REFRACTORY METASTATIC PROSTATE-CANCER
    STERNBERG, CN
    ANNALS OF ONCOLOGY, 1992, 3 (05) : 331 - 335
  • [50] METASTATIC PROSTATE-CANCER TO THE OPTIC CANAL
    KATTAH, JC
    CHROUSOS, GC
    ROBERTS, J
    KOLSKY, M
    ZIMMERMAN, L
    MANZ, H
    OPHTHALMOLOGY, 1993, 100 (11) : 1711 - 1715
12345